128 related articles for article (PubMed ID: 8241995)
21. Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an alpha-particle-emitting immunoconjugate.
Zalutsky MR; Stabin MG; Larsen RH; Bigner DD
Nucl Med Biol; 1997 Apr; 24(3):255-61. PubMed ID: 9228660
[TBL] [Abstract][Full Text] [Related]
22. N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.
Shankar S; Vaidyanathan G; Affleck D; Welsh PC; Zalutsky MR
Bioconjug Chem; 2003; 14(2):331-41. PubMed ID: 12643743
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.
Smellie WJ; Dean CJ; Sacks NP; Zalutsky MR; Garg PK; Carnochan P; Eccles SA
Cancer Res; 1995 Dec; 55(23 Suppl):5842s-5846s. PubMed ID: 7493357
[TBL] [Abstract][Full Text] [Related]
24. Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody.
Foulon CF; Reist CJ; Bigner DD; Zalutsky MR
Cancer Res; 2000 Aug; 60(16):4453-60. PubMed ID: 10969792
[TBL] [Abstract][Full Text] [Related]
25. Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.
Reist CJ; Archer GE; Kurpad SN; Wikstrand CJ; Vaidyanathan G; Willingham MC; Moscatello DK; Wong AJ; Bigner DD; Zalutsky MR
Cancer Res; 1995 Oct; 55(19):4375-82. PubMed ID: 7671250
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of anti-tenascin monoclonal antibody-streptavidin conjugates for pretargeting applications.
Foulon CF; Bigner DD; Zalutsky MR
Bioconjug Chem; 1999; 10(5):867-76. PubMed ID: 10502355
[TBL] [Abstract][Full Text] [Related]
27. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
[TBL] [Abstract][Full Text] [Related]
28. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
Zalutsky MR; Narula AS
Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis.
Bourdon MA; Coleman RE; Blasberg RG; Groothuis DR; Bigner DD
Anticancer Res; 1984; 4(3):133-40. PubMed ID: 6465851
[TBL] [Abstract][Full Text] [Related]
30. Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate.
Vaidyanathan G; Zalutsky MR
Int J Rad Appl Instrum B; 1992 Apr; 19(3):275-81. PubMed ID: 1629016
[TBL] [Abstract][Full Text] [Related]
31. Human/murine chimeric 81C6 F(ab')(2) fragment: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma.
Boskovitz A; Akabani GH; Pegram CN; Bigner DD; Zalutsky MR
Nucl Med Biol; 2004 Apr; 31(3):345-55. PubMed ID: 15028247
[TBL] [Abstract][Full Text] [Related]
32. Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1990; 1(4):269-73. PubMed ID: 2096920
[TBL] [Abstract][Full Text] [Related]
33. Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography.
Vaidyanathan G; Bigner DD; Zalutsky MR
J Nucl Med; 1992 Aug; 33(8):1535-41. PubMed ID: 1634947
[TBL] [Abstract][Full Text] [Related]
34. Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability.
Garg PK; Slade SK; Harrison CL; Zalutsky MR
Int J Rad Appl Instrum B; 1989; 16(7):669-73. PubMed ID: 2613522
[TBL] [Abstract][Full Text] [Related]
35. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
[TBL] [Abstract][Full Text] [Related]
37. SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.
Vaidyanathan G; White BJ; Affleck DJ; Zhao XG; Welsh PC; McDougald D; Choi J; Zalutsky MR
Bioorg Med Chem; 2012 Dec; 20(24):6929-39. PubMed ID: 23159039
[TBL] [Abstract][Full Text] [Related]
38. The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody.
Hauck ML; Zalutsky MR
Clin Cancer Res; 1998 Sep; 4(9):2071-7. PubMed ID: 9748121
[TBL] [Abstract][Full Text] [Related]
39. Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.
Yordanov AT; Hens M; Pegram C; Bigner DD; Zalutsky MR
Nucl Med Biol; 2007 Feb; 34(2):173-83. PubMed ID: 17307125
[TBL] [Abstract][Full Text] [Related]
40. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
